Harmine antagonism of drug-induced extra-pyramidal disturbances.
D000470:Alkaloids / Q000627:therapeutic use*; D000927:Anticonvulsants / Q000627:therapeutic use*; D002746:Chlorpromazine / Q000009:adverse effects*; D002986:Clinical Trials as Topic; D004660:Encephalitis / Q000150:complications; D005260:Female; D006801:Humans; D008297:Male; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000188:drug therapy*; D010919:Placebos; D012110:Reserpine / Q000009:adverse effects*
D000470:Alkaloids; D000927:Anticonvulsants; D008996:Monoamine Oxidase Inhibitors; D010919:Placebos; D012110:Reserpine; D002746:Chlorpromazine